Literature DB >> 22081924

Metastatic lymph nodes in hilar cholangiocarcinoma: does size matter?

Anthony T Ruys1, Fiebo J W Ten Kate, Olivier R Busch, Marc R Engelbrecht, Dirk J Gouma, Thomas M van Gulik.   

Abstract

AIM: To determine the diagnostic efficacy of the size criteria for the detection of metastatic lymph nodes (LN) in patients with hilar cholangiocarcinoma (HCCA).
INTRODUCTION: LN metastasis is one of the most significant independent prognostic factors in patients with HCCA. Presently, in spite of the well known lack of sensitivity and specificity, one of the most used clinical criteria for nodal metastases is LN size.
METHODS: Pathological slides of 147 patients who had undergone exploration for HCCA were assessed. The size (maximum and short axis diameter) of each single node was retrieved from the pathology report or measured from a section on the glass slide using a stereo microscope and a calibrated ruler integrated in the software. When a metastatic lesion was detected, the proportion of the lesion in relation to LN size was estimated.
RESULTS: Out of 147 patients, 645 LN were retrieved and measured. In all, 106 nodes (16%) showed evidence of metastasis. The proportion of positive nodes was 8% in nodes <5 mm and 37% in nodes >30 mm. Ten per cent of LN smaller than 10 mm were positive, whereas only 23% of LN larger than 10 mm were metastastically involved. No clear cut-off point could be found. Similar results were found for the short axis diameter. In 50% of positive LN, the metastatic lesion accounted for 10% or less of the LN size.
CONCLUSION: No cut-off point could be determined for accurately predicting nodal involvement. Therefore, imaging studies should not rely on LN size when assessing nodal involvement.
© 2011 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2011        PMID: 22081924      PMCID: PMC3244628          DOI: 10.1111/j.1477-2574.2011.00389.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  28 in total

1.  Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Authors:  W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

2.  Improved survival in resected biliary malignancies.

Authors:  Attila Nakeeb; Khoi Q Tran; Michael J Black; Beth A Erickson; Paul S Ritch; Edward J Quebbeman; Stuart D Wilson; Michael J Demeure; William S Rilling; Kulwinder S Dua; Henry A Pitt
Journal:  Surgery       Date:  2002-10       Impact factor: 3.982

3.  The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer.

Authors:  H Kotanagi; T Fukuoka; Y Shibata; T Yoshioka; O Aizawa; Y Saito; G E Tur; K Koyama
Journal:  J Surg Oncol       Date:  1993-12       Impact factor: 3.454

4.  Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group.

Authors:  Y Sugiura; S Nakamura; S Iida; Y Hosoda; S Ikeuchi; S Mori; A Sugioka; T Tsuzuki
Journal:  Surgery       Date:  1994-04       Impact factor: 3.982

5.  Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection.

Authors:  Y Kitagawa; M Nagino; J Kamiya; K Uesaka; T Sano; H Yamamoto; N Hayakawa; Y Nimura
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 6.  Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.

Authors:  T Kosuge; J Yamamoto; K Shimada; S Yamasaki; M Makuuchi
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

7.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

8.  Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.

Authors:  Tomoki Ebata; Masato Nagino; Junichi Kamiya; Katsuhiko Uesaka; Tetsuro Nagasaka; Yuji Nimura
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

9.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.

Authors:  Mukesh G Harisinghani; Jelle Barentsz; Peter F Hahn; Willem M Deserno; Shahin Tabatabaei; Christine Hulsbergen van de Kaa; Jean de la Rosette; Ralph Weissleder
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Staging laparoscopy for hilar cholangiocarcinoma: is it still worthwhile?

Authors:  Anthony T Ruys; Olivier R Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2011-02-23       Impact factor: 5.344

View more
  13 in total

1.  American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions.

Authors:  Bas Groot Koerkamp; Jimme K Wiggers; Peter J Allen; Olivier R C Busch; Michael I D'Angelica; Ronald P DeMatteo; Yuman Fong; Mithat Gonen; Dirk J Gouma; T Peter Kingham; Thomas M van Gulik; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2014-09-29       Impact factor: 3.647

Review 2.  Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Langenbecks Arch Surg       Date:  2014-05-20       Impact factor: 3.445

3.  Extrahepatic biliary cancer: New staging classification.

Authors:  Dhakshinamoorthy Ganeshan; Fanny E Moron; Janio Szklaruk
Journal:  World J Radiol       Date:  2012-08-28

4.  Safety and feasibility of laparoscopic liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institution.

Authors:  Francesca Ratti; Federica Cipriani; Riccardo Ariotti; Annalisa Gagliano; Michele Paganelli; Marco Catena; Luca Aldrighetti
Journal:  Surg Endosc       Date:  2015-07-21       Impact factor: 4.584

5.  Adjuvant treatment in biliary tract cancer: to treat or not to treat?

Authors:  Stefano Cereda; Carmen Belli; Michele Reni
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

6.  A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma.

Authors:  Gu-Wei Ji; Fei-Peng Zhu; Yu-Dong Zhang; Xi-Sheng Liu; Fei-Yun Wu; Ke Wang; Yong-Xiang Xia; Yao-Dong Zhang; Wang-Jie Jiang; Xiang-Cheng Li; Xue-Hao Wang
Journal:  Eur Radiol       Date:  2019-03-26       Impact factor: 5.315

7.  Risk factors and classifications of hilar cholangiocarcinoma.

Authors:  Miguel Angel Suarez-Munoz; Jose Luis Fernandez-Aguilar; Belinda Sanchez-Perez; Jose Antonio Perez-Daga; Beatriz Garcia-Albiach; Ysabel Pulido-Roa; Naiara Marin-Camero; Julio Santoyo-Santoyo
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

8.  The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma.

Authors:  Ying Chen; Zhanshan Cha; Wenzheng Fang; Baohua Qian; Wenlong Yu; Wenfeng Li; Guanzhen Yu; Yong Gao
Journal:  Oncotarget       Date:  2015-08-21

9.  Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System.

Authors:  Jong Woo Lee; Jae Hoon Lee; Yejong Park; Woohyung Lee; Jaewoo Kwon; Ki Byung Song; Dae Wook Hwang; Song Cheol Kim
Journal:  Cancer Res Treat       Date:  2020-03-12       Impact factor: 4.679

10.  Prognostic impact of preoperative imaging parameters on resectability of hilar cholangiocarcinoma.

Authors:  Anthony T Ruys; Olivier R Busch; Erik A Rauws; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB Surg       Date:  2013-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.